Taxol is known to polymerize and stabilize microtubules and thereby al
ter many cellular functions. Our studies examined the effects of taxol
pretreatment of tumor targets and cytotoxic effector cells in an effo
rt to determine whether such treatment would result in increased tumor
cell lysis without affecting cytotoxic cell function. Our studies dem
onstrated that taxol concentrations of 6-30 ng/ml which induced simila
r to 50% growth inhibition and greater than or equal to 50% block in t
he G(2)/M phase of the K562 cell targets did not have any significant
effect on the functional ability of NK cells to lyse K562 cells. Pretr
eatment of K562 cells with taxol (6 and 30 ng/ml) resulted in an incre
ase in K562 cell lysis by NK cells (or NK cells stimulated with 100 un
its/ml of rIL-2) in 7 out of 9 donors. The amplification of NK cell-me
diated lysis of tumor targets due to taxol pretreatment may provide a
combination therapeutic approach which includes taxol treatment follow
ed by rIL-2 stimulation of the immune killer cell function.